Suicide gene therapy on spontaneous canine melanoma: Correlations between in vivo tumors and their derived multicell spheroids in vitro

Gene Therapy

Volumn 17, Issue 1, 2010, Pages 26-36

  Gil Cardeza, M L ^a   Villaverde, M S ^a   Fiszman, G L ^a   Altamirano, N A ^a   Cwirenbaum, R A ^a   Glikin, G C ^a   Finocchiaro, L M E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

DMRIE; HSV thymidine kinase; Lipofection; Melanoma; Multicellular resistance; Spheroids

Indexed keywords

ACICLOVIR; GANCICLOVIR; HERPES SIMPLEX VIRUS THYMIDINE KINASE; LIPOPLEX; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL GROWTH; DOG DISEASE; DRUG RESPONSE; DRUG SENSITIVITY; GENETIC TRANSFECTION; MELANOMA; MULTICELLULAR SPHEROID; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE THERAPY;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DOG DISEASES; DOGS; GANCICLOVIR; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; MELANOMA; MODELS, BIOLOGICAL; SIMPLEXVIRUS; SPHEROIDS, CELLULAR; THYMIDINE KINASE;

HERPES; SIMPLEXVIRUS;

EID: 74349084695     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.107     Document Type: Article

References (22)

1. Ramos-Vara JA, Beissenherz ME, Miller MA, Johnson GC, Pace LW, Fard A et al. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol 2000; 37: 597-608.
2. Smith SH, Goldschmidt MH, McManus PM. A comparative review of melanocytic neoplasms. Vet Pathol 2002; 39: 651-678.
3. Finocchiaro LME, Fiszman GL, Karara AL, Glikin GC. Suicide gene and cytokines combined non viral gene therapy for canine spontaneous melanoma. Cancer Gene Ther 2008; 15: 165-172.
4. Finocchiaro LME, Glikin GC. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma. Gene Therapy 2008; 15: 267-276.
5. Altamirano NA, Karara AL, Villaverde MS, Fiszman GL, Glikin GC, Finocchiaro LME (2007). Spontaneous canine melanoma derived spheroids display individual multicellular resistance patterns to suicide gene and chemotherapy. In: Torres LS (ed). Cancer Drug Resistance Research Perspectives. Nova Science Publishers, Inc.: New York., pp 119-137, ISBN: 1-60021-572-6.
6. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res 2000; 60: 3989-3999.
7. Desoize B, Jardillier JC. Multicellular resistance: a paradigm for clinical resistance? Crit Rev Oncol Hematol 2000; 36: 193-207.
8. Santini MT, Rainaldi G. Three-dimensional spheroid model in tumor biology. Pathobiology 1999; 67: 148-157.
9. Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 1998; 240: 177-184.
10. Finocchiaro LME, Bumaschny VF, Karara AL, Fiszman GL, Casais CC, Glikin GC. Herpes simplex virus thymidine kinase/ ganciclovir system in multicellular tumor spheroids. Cancer Gene Ther 2004; 11: 333-345.
11. Karara AL, Bumaschny VF, Fiszman GL, Casais CC, Glikin GC, Finocchiaro LM. Lipofection of early passages of cell cultures derived from murine adenocarcinomas: in vitro and ex vivo testing of the thymidine kinase/ganciclovir system. Cancer Gene Ther 2002; 8: 96-99.
12. MacGregor GR, Caskey T. Construction of plasmids that express E coli b-galactosidase in mammalian cells. Nucleic Acids Res 1989; 17: 2365-2365
13. Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994; 269: 2550-2561.
14. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Therapy 1995; 2: 710-722.
15. Casais CC, Karara AL, Glikin GC, Finocchiaro LME. Effects of spatial configuration on tumor cells transgene expression. Gene Ther Mol Biol 2006; 10: 207-222.
16. Inoue K, Ohashi E, Kadosawa T, Hong SH, Matsunaga S, Mochizuki M et al. Establishment and characterization of four canine melanoma cell lines. J Vet Med Sci 2004; 66: 1437-1440.
17. Hendrix MJ, Seftor EA, Chu YW, Seftor RE, Nagle RB, McDaniel KM et al. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential. J Natl Cancer Inst 1992; 84: 165-174.
18. Koenig A, Wojcieszyn J, Weeks BR, Modiano JF. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma. Vet Pathol 2001; 38: 427-435.
19. Mueller-Klieser W. Tumor biology experimental therapeutics. Critical Rev Oncol Hematol 2000; 36: 123-139.
20. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408-1416.
21. Siemann DW. The tumor microenvironment: a double-edged sword. Int J Radiat Oncol Biol Phys 1998; 42: 697-699.
22. Spangler WL, Kass PH. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet Pathol 2006; 43: 136-149.